Skip to main content
. 2020 Aug;9(4):1112–1123. doi: 10.21037/tlcr-19-577

Figure 4.

Figure 4

The Benefit analysis of adjuvant chemotherapy (ACT) in different subgroups. (A) Patients in the low-risk groups defined by the nomogram showed no survival difference between with and without ACT; (B) patients in the high-risk groups defined by the nomogram could obtain survival benefits from ACT.